For laboratory research use only - not for human consumption

Hub ยท Peptide Quality & Verification

Types of peptide impurities in synthetic peptides

Synthetic peptide impurities fall into two broad groups. Peptide-related impurities contain parts of the intended sequence, such as deletion and truncated sequences or oxidation and deamidation products. Non-peptide impurities include process reagents, residual solvents and elemental impurities. A European Medicines Agency guideline separates them this way, and different tests look for different groups.

Published 2026-11-17Updated 2026-11-17Written by Form Laboratories research team5 min read

Picture a batch of cakes from a bakery. Some come out with a corner missing. Some go stale on the shelf. Some carry a trace of the tray's oil. Each flaw has a different cause, and you would spot each one a different way. A peptide made in a laboratory has the same pattern: its flaws come in families, and no single check sees them all.

This page is part of the peptide quality and verification hub. It names the main families of impurity in a synthetic peptide and shows which kind of test looks for which. It is research reference material, for research use only. The peak-area limits of a purity figure are covered on the HPLC purity page, so this page does not repeat them.

Key facts

Key facts for Types of peptide impurities: sequence-related, degradation and non-peptide
SourceEuropean Medicines Agency (EMA) Guideline on the Development and Manufacture of Synthetic Peptides, EMA/CHMP/CVMP/QWP/367182/2025, dated 4 December 2025
Scope of that guidelineSynthetic peptides used in a medicinal product. It is not a rule for research products
Two broad groupsPeptide-related impurities and non-peptide impurities
Sequence-related examplesDeletion sequences, truncated sequences, insertion sequences and stereoisomers
Degradation examplesOxidation, hydrolysis, deamidation and isomerisation, among other pathways
Non-peptide examplesProcess reagents and by-products, residual solvents, elemental impurities and nitrosamines
Results shown for Form Laboratories productsNone on this page
UseResearch reference material. Not for human or animal use
EMA synthetic-peptide guideline 2025

What are the main types of peptide impurities?

The EMA guideline says impurities are often categorised as peptide-related or non-peptide. Peptide-related impurities contain structural elements of the synthetic peptide sequence. Non-peptide impurities include process reagents and their by-products, residual solvents, elemental impurities and nitrosamines. The guideline calls purity one of the most important critical quality attributes for synthetic peptides. It is dated 4 December 2025, came into effect on 1 June 2026 and applies to peptides used in medicinal products, so this page does not present it as a rule for research products.

The guideline names three sources of peptide-related impurities: the starting materials, formation during manufacture, and degradation during manufacture or storage. Some related substances can come from more than one of these at once.

EMA synthetic-peptide guideline 2025

What are degradation impurities such as oxidation and deamidation?

Degradation products are peptides changed after they were made. The guideline lists these pathways: oxidation, hydrolysis, isomerisation, deamidation, cyclic imide formation, diketopiperazine and pyroglutamic acid formation, beta-elimination, condensation, disulfide cleavage or exchange, and acetylation. It says their content may increase during storage. It also says the likely pathways should be discussed in light of the peptide's amino acid composition and sequence.

The guideline classes aggregates, dimers and oligomers as high molecular weight impurities, formed during synthesis or storage. That is a separate family again, with a separate test named later on this page.

EMA synthetic-peptide guideline 2025

What are non-peptide impurities such as residual solvents?

Non-peptide impurities are material in the sample that is not a form of the peptide. The guideline names process reagents, by-products, residual solvents, elemental impurities and nitrosamines. Solid-phase synthesis washes the resin with solvents, and the guideline says the purge of every reagent and solvent should be addressed. Its specification list also has separate lines for counter-ion identity and content, residual trifluoroacetic acid (TFA) and water content.

A counter-ion is a small charged particle that comes with the peptide. The guideline notes that the type of counter-ion can affect the peptide's biological and physicochemical properties, and that acetate is usually used, with trifluoroacetate or chloride also possible.

EMA synthetic-peptide guideline 2025

Do different tests look for different impurity types?

Yes. The guideline lists separate specification tests: purity, with total and individual impurities; high molecular weight impurities by size-exclusion chromatography (SEC-LC) or other techniques; assay or content; counter-ion content; water content; residual solvents; elemental impurities; bacterial endotoxins; and microbiological purity. It also says that if one method cannot separate all the peptide-related impurities, additional independent methods may be needed. One test result therefore does not cover every family.

A chromatographic purity figure reads peak area on one method. The HPLC purity page covers what that figure can and cannot show. The mass spectrometry page covers identity, and the endotoxin, sterility and purity page covers the microbiological tests.

EMA synthetic-peptide guideline 2025

Evidence limits

What does this page not show?

This page shows no impurity result for any Form Laboratories product. The EMA guideline covers synthetic peptides in medicinal products, human and veterinary. It does not set rules for research material, and this page does not claim that it does. It states no more than the guideline does. Form Laboratories supplies research material for research use only, not for human or animal use.

Ask any supplier which tests a batch has had. The answer belongs on a dated report that names the batch, the method and the test. A report that lists one test says nothing about the families that test does not look for.

Comparison

Each impurity family, an example from the EMA guideline and the kind of test the guideline lists for it. Taken from EMA/CHMP/CVMP/QWP/367182/2025, which covers medicinal products and is not a rule for research products.

Comparison: Types of peptide impurities: sequence-related, degradation and non-peptide
FamilyExamples namedTest the guideline listsNot covered by
Sequence-relatedDeletion, truncated and insertion sequences, stereoisomersPurity: total and individual impurities, with extra independent methods where neededA single test that cannot separate every related impurity
Degradation productsOxidation, deamidation, hydrolysis, isomerisationPurity and stability studiesAnything the chosen method cannot separate
AggregatesDimers, trimers, oligomers, aggregatesHigh molecular weight impurities by SEC-LC or other techniquesA purity figure alone
Non-peptide materialResidual solvents, process reagents, elemental impurities, counter-ionsResidual solvents, elemental impurities, counter-ion content, water contentA chromatographic purity figure

FAQ

What are the main types of peptide impurities?

The EMA guideline groups them as peptide-related impurities, which contain parts of the intended sequence, and non-peptide impurities, such as process reagents, residual solvents and elemental impurities. The guideline covers peptides in medicinal products.

What is a deletion or truncated sequence?

A deletion sequence is a peptide with one or several amino acids missing, through incomplete coupling or deprotection. A truncated sequence is an acetylated fragment left when unreacted sites are capped during solid-phase synthesis (EMA guideline, 2025).

What are oxidation and deamidation in peptides?

They are two of the degradation pathways the EMA guideline lists, with hydrolysis, isomerisation and others. The guideline says the content of degradation products may increase during storage.

Does one purity test find every impurity?

No. The EMA guideline lists separate tests for purity, high molecular weight impurities, content, counter-ions, water, residual solvents, elemental impurities, endotoxins and microbiological purity. It also says additional independent methods may be needed to separate all peptide-related impurities.

Does this page show impurity results for Form Laboratories products?

No. It describes impurity categories only and shows no result for any Form Laboratories product. Form Laboratories supplies research material for research use only, not for human or animal use.

Citations

1 sources
  1. European Medicines Agency Guideline on the Development and Manufacture of Synthetic Peptides (EMA/CHMP/CVMP/QWP/367182/2025). 4 December 2025.
    https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-development-manufacture-synthetic-peptides_en.pdf

Written by

Form Laboratories research team

Perth, Western Australia. We supply research-use-only reference material.

Written in-house
These articles are written and maintained by our own research team, not by a named clinician.
Built from the record
Every figure comes from published literature, listed in full above with a link to the original paper.
No use directions
We describe what the research measured. We give no use directions, preparation steps or advice.

Form Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.

2026 Form Laboratories - Research use only - Perth WAPerth WA 6000 - dispatched Australia-wide via Australia Post or CouriersPlease